Literature DB >> 8456325

Recombinant blood clotting proteins for hemophilia therapy.

S A Limentani1, D A Roth, B C Furie, B Furie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8456325     DOI： 10.1055/s-2007-994007

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  3 in total

Review 1.  Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research.

Authors:  E Gonzalez; E E Moore; H B Moore; M P Chapman; C C Silliman; A Banerjee
Journal:  Scand J Surg       Date:  2014-04-30       Impact factor: 2.360

Review 2.  Management of bleeding disorders by prohemostatic therapy.

Authors:  Marcel M Levi; Roel Vink; Evert de Jonge
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.

Authors:  S Gillis; B C Furie; B Furie; H Patel; M C Huberty; M Switzer; W B Foster; H A Scoble; M D Bond
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.